About The University of Alabama at Birmingham, Department of Dermatology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
3
Clinical Trials at The University of Alabama at Birmingham, Department of Dermatology
During the past decade, The University of Alabama at Birmingham, Department of Dermatology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
2018-03-08
2025-06-30
Active, not recruiting
3,163
Long-Term PF-06651600 for the Treatment of Alopecia Areata
2019-07-18
2026-02-03
Active, not recruiting
1,050
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at The University of Alabama at Birmingham, Department of Dermatology
According to Clinical.Site data, the most researched conditions in "The University of Alabama at Birmingham, Department of Dermatology" are
"Alopecia Areata" (2 trials) and "Dermatitis, Atopic" (1 trials). Many other conditions were trialed in "The University of Alabama at Birmingham, Department of Dermatology" in a lesser frequency.
Clinical Trials Intervention Types at The University of Alabama at Birmingham, Department of Dermatology
Most popular intervention types in "The University of Alabama at Birmingham, Department of Dermatology" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Abrocitinib 100 mg" (1 trials), "Abrocitinib 200 mg" (1 trials), "Meningococcal (groups A, C, W-135 and Y [ACWY]) oligosaccharide diphtheria CRM197 conjugate vaccine" (1 trials) and "PF-06651600" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The University of Alabama at Birmingham, Department of Dermatology
The vast majority of trials in "The University of Alabama at Birmingham, Department of Dermatology" are
3 trials for "All" genders.
Clinical Trials Status at The University of Alabama at Birmingham, Department of Dermatology
Currently, there are NaN active trials in "The University of Alabama at Birmingham, Department of Dermatology".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in The University of Alabama at Birmingham, Department of Dermatology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in The University of Alabama at Birmingham, Department of Dermatology, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".